Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GSK3B | P49841 | 4/20 | 0.52 |
| ▸ | ROCK1 | Q13464 | 4/20 | 0.52 |
| ▸ | ROCK2 | O75116 | 3/20 | 0.52 |
| ▸ | PRKG1 | Q13976 | 3/20 | 0.52 |
| ▸ | CLK4 | Q9HAZ1 | 3/20 | 0.52 |
| ▸ | GSK3A | P49840 | 3/20 | 0.52 |
| ▸ | QPCT | Q16769 | 5/20 | 0.51 |
| ▸ | MEN1 | O00255 | 2/20 | 0.48 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.48 |
| ▸ | POLB | P06746 | 1/20 | 0.48 |
| ▸ | PRKACA | P17612 | 3/20 | 0.46 |
| ▸ | RPS6KB1 | P23443 | 3/20 | 0.46 |
| ▸ | RPS6KA3 | P51812 | 3/20 | 0.46 |
| ▸ | CDC42BPA | Q5VT25 | 3/20 | 0.46 |
| ▸ | AURKB | Q96GD4 | 3/20 | 0.46 |
| ▸ | CDK1 | P06493 | 2/20 | 0.46 |
| ▸ | CHEK1 | O14757 | 2/20 | 0.46 |
| ▸ | DAPK3 | O43293 | 2/20 | 0.46 |
| ▸ | CHEK2 | O96017 | 2/20 | 0.46 |
| ▸ | AKT1 | P31749 | 2/20 | 0.46 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4906532 | 0.91 | ROCK2 (0.45) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4597195 | 0.91 | ROCK2 (0.44) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4907610 | 0.89 | ROCK1 (0.43) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4598322 | 0.87 | ROCK2 (0.44) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4897991 | 0.87 | RPS6KB1 (0.43) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4905587 | 0.85 | ROCK1 (0.48) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL14066718 | 0.85 | MAPKAPK2 (0.54) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4908365 | 0.85 | ROCK2 (0.43) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4910893 | 0.85 | ROCK1 (0.47) | GSK3BROCK1ROCK2PRKG1CLK4 | |
| SCHEMBL4908299 | 0.85 | ROCK2 (0.48) | GSK3BROCK1ROCK2PRKG1CLK4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | MERCK PATENT GESELLSCHAFT (DE) | 2008-09-25 | — | — | US | claimed |
| EP-1910312-A1 | QUADRATIC ACID II DERIVATIVES | Merck Patent GmbH (DE) | 2008-04-16 | — | — | EP | claimed |
| WO-2007014608-A1 | QUADRATIC ACID II DERIVATIVES | MERCK PATENT GMBH (DE) | 2007-02-08 | — | — | WO | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20080234266-A1 | Squaric Acid Derivatives II | CHEK2, CHEK1, SGK3 | GSK3B 132/4885ROCK1 713/4885ROCK2 662/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.